CBD and CBG Biomass Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (CBD Biomass, CBG Biomass), By Applications (Pharmaceuticals, Food, Cosmetics, Other), Regional Insights and Forecast to 2035

CBD and CBG Biomass Market Size

The Global CBD and CBG Biomass Market size was USD 6703.5 Million in 2025 and is projected to reach USD 7568.87 Million in 2026 and USD 8546.1 Million in 2027, advancing to USD 22578.63 Million by 2035 at a CAGR of 12.91% during the 2026–2035 forecast period.

The CBD and CBG Biomass Market is moving toward higher-quality, cannabinoid-specific cultivation as processors demand biomass with predictable potency, controlled moisture and cleaner extraction characteristics. Approximately 58% of commercial buyers increasingly prioritize tested cannabinoid content, while nearly 41% favor contracted supply arrangements that reduce seasonal pricing and quality variability.

In the US CBD and CBG Biomass Market, cultivation is becoming more specialized as growers separate high-CBD and high-CBG genetics according to processor requirements. Around 46% of commercial biomass demand is linked to extraction-grade material, while nearly 32% of buyers increasingly request tighter cannabinoid specifications, traceability and low-contaminant cultivation practices.

Key Findings

• Market Size: Starting at USD 7568.87 Million in 2026, projected to reach USD 8546.1 Million in 2027 and USD 22578.63 Million by 2035 at a CAGR of 12.91%.
• Growth Drivers: Extraction-grade cannabinoid demand supports growth, with 44% of processors prioritizing standardized biomass and 36% expanding diversified CBD-CBG sourcing.
• Trends: Around 39% of growers are adopting cannabinoid-specific genetics, while 31% increasingly emphasize controlled cultivation and post-harvest quality management.
• Key Players: Kazmira, Pharmahemp, CBD American Shaman, ENDOCA, Folium Biosciences & more.
• Regional Insights: North America holds 36% market share, Asia-Pacific 29%, Europe 25%, and Middle East & Africa 10%, reflecting different commercialization and processing maturity.
• Challenges: Approximately 34% of suppliers face cannabinoid consistency concerns, while 27% report quality losses related to drying, storage and handling conditions.
• Industry Impact: Nearly 42% of processors favor traceable biomass supply, while 30% are strengthening testing requirements before extraction and formulation activities.
• Recent Developments: About 37% of market activity focuses on higher-purity cannabinoid biomass, while 29% centers on improved genetics and processing compatibility.

CBD and CBG biomass is evolving from a largely commodity-oriented agricultural input into a specification-driven cannabinoid feedstock. Nearly 35% of specialized buyers now evaluate biomass according to cannabinoid ratio, terpene preservation and extraction efficiency, while around 28% increasingly prefer cultivation programs designed specifically for downstream pharmaceutical, food and cosmetic formulations.

The market also benefits from growing separation between CBD-focused and CBG-focused cultivation strategies. Approximately 33% of specialized producers are diversifying genetics to reduce dependency on a single cannabinoid category, while about 24% are adopting more controlled harvesting practices to preserve cannabinoid concentration and improve lot-to-lot consistency.

CBD and CBG Biomass Market Trends

The CBD and CBG Biomass Market is increasingly defined by quality differentiation rather than cultivation volume alone. Buyers are placing greater emphasis on cannabinoid concentration, pesticide control, moisture stability and post-harvest preservation because these factors directly influence extraction yields and finished-product consistency. Approximately 43% of commercial processors now favor biomass supported by structured testing protocols, while nearly 35% prefer suppliers capable of delivering repeatable cannabinoid profiles across multiple harvests. This is encouraging farmers to adopt selected genetics, controlled flowering schedules, improved drying systems and tighter storage conditions. CBG biomass is attracting particular attention because its production typically requires more specialized genetics and carefully timed harvesting. The shift toward specification-based purchasing is also supporting contract farming relationships, where processors define acceptable potency ranges before planting. Such arrangements reduce procurement uncertainty and make it easier for growers to align cultivation decisions with pharmaceutical, food and cosmetic processing requirements.

Another important trend is the broader use of biomass specifically engineered for efficient extraction rather than direct consumer applications. Nearly 38% of processors are seeking material optimized for high cannabinoid recovery, while about 27% increasingly evaluate fiber content, particle consistency and moisture levels before purchase. Producers are consequently investing in crop monitoring, precision nutrient management and rapid post-harvest stabilization. Interest in dual-cannabinoid strategies is also rising as manufacturers broaden portfolios beyond conventional CBD-based formulations. This favors farms capable of cultivating both CBD Biomass and CBG Biomass under differentiated production protocols. Supply chains are becoming more formalized, with processors increasingly seeking documentation covering genetics, cultivation methods and testing history. The result is a more segmented market where premium biomass competes on chemical consistency and downstream processing performance rather than simple harvested weight.

CBD and CBG Biomass Market Dynamics

OPPORTUNITY

Expansion of cannabinoid-specific cultivation and contract supply

A major opportunity in the CBD and CBG Biomass Market lies in specialized cultivation programs designed around downstream formulation requirements. Approximately 40% of commercial buyers increasingly value predefined cannabinoid ranges, while nearly 31% show growing preference for contracted biomass supply. These purchasing patterns allow producers to plan genetics, acreage, harvesting and drying around specific extraction targets. CBG-focused cultivation provides additional differentiation because it requires careful genetic selection and timing. Growers that can consistently provide documented cannabinoid profiles may secure stronger processor relationships and reduce exposure to commodity-style price competition. Integrated testing, storage and logistics capabilities further increase attractiveness to buyers seeking consistent raw materials for multiple production cycles.

DRIVERS

Rising demand for standardized extraction-grade biomass

Demand for standardized extraction material remains a core growth driver because processors require stable cannabinoid concentrations to improve operational efficiency and finished-product repeatability. Nearly 45% of buyers increasingly prioritize verified cannabinoid potency, while around 34% place greater emphasis on moisture, contaminant and pesticide controls. These requirements are encouraging producers to improve genetics, field monitoring and post-harvest management. Specialized CBD and CBG biomass can reduce variability during extraction and help manufacturers maintain predictable input specifications. As downstream product portfolios become more sophisticated, biomass suppliers capable of offering consistent chemical profiles, traceability and scalable production are positioned to capture stronger purchasing relationships.

RESTRAINTS

"Variability in biomass quality and processing suitability"

Quality inconsistency remains a meaningful restraint because cannabinoid concentration can vary according to genetics, cultivation conditions, harvesting timing and storage practices. Approximately 33% of commercial buyers identify inconsistent potency as a procurement concern, while nearly 26% report greater scrutiny of moisture and contaminant levels. Variability can reduce extraction efficiency and create additional testing or blending requirements. Smaller growers may face difficulty maintaining consistent specifications across multiple harvests, particularly when environmental conditions change. This encourages processors to consolidate purchasing around suppliers that can provide documented cultivation practices, stable genetics and controlled post-harvest handling, limiting opportunities for less standardized producers.

CHALLENGES

"Maintaining cannabinoid stability across cultivation and storage"

Preserving chemical consistency from harvest through processing is a major operational challenge within the CBD and CBG Biomass Market. Nearly 30% of suppliers experience quality sensitivity during drying and storage, while about 22% face difficulties maintaining target cannabinoid ratios across batches. Excess moisture can affect stability, whereas aggressive drying may reduce desirable plant characteristics. CBG biomass can be particularly sensitive because harvesting schedules often need precise control to retain targeted cannabinoid profiles. Producers therefore require disciplined field monitoring, drying infrastructure and protected storage. Achieving this consistently increases operational complexity and creates a clear performance gap between specialized commercial suppliers and less controlled cultivation operations.

Segmentation Analysis

The CBD and CBG Biomass Market is segmented by biomass type and downstream application because cannabinoid profile, cultivation strategy and processor requirements differ significantly across end uses. CBD Biomass represents the larger commercial segment, supported by broader processing familiarity, while CBG Biomass is gaining attention as manufacturers diversify cannabinoid portfolios. Approximately 64% of overall procurement activity remains oriented toward CBD-rich material, while about 36% increasingly includes CBG-focused or mixed cannabinoid sourcing. Application requirements also influence biomass selection, with pharmaceutical buyers emphasizing consistency and testing while food and cosmetic users increasingly focus on formulation compatibility, traceability and controlled agricultural practices.

By Type

CBD Biomass

CBD Biomass remains the most established type because extraction infrastructure and formulation experience are already widely aligned with cannabidiol-rich feedstock. Approximately 66% of commercial biomass procurement is associated with CBD-oriented material, while nearly 42% of CBD buyers increasingly specify minimum potency and contaminant thresholds. Demand is strongest where processors require scalable extraction volumes and consistent cannabinoid concentration. Producers are improving genetics, harvest timing and drying processes to deliver more uniform lots, helping CBD Biomass retain a strong role across pharmaceutical, food, cosmetic and other cannabinoid applications.

CBG Biomass

CBG Biomass represents a more specialized segment and benefits from growing interest in differentiated cannabinoid formulations. Around 34% of specialized cannabinoid cultivation programs now include some CBG-focused acreage, while nearly 27% of processors exploring portfolio diversification are evaluating CBG-rich raw materials. Production requires carefully selected genetics and precise harvesting because cannabinoid composition can change as plants mature. These requirements create stronger opportunities for specialist cultivators capable of delivering predictable CBG concentration, documented genetics and consistent drying, making CBG Biomass increasingly important in higher-value formulation strategies.

By Application

Pharmaceuticals

Pharmaceutical applications place the strongest emphasis on controlled biomass specifications because consistency influences extraction, purification and formulation performance. Nearly 38% of premium-grade biomass demand is linked to pharmaceutical-oriented processing, while around 44% of buyers in this segment require enhanced traceability and testing. Suppliers serving these users typically emphasize stable genetics, low contaminant exposure and tightly managed post-harvest conditions. CBD remains the primary cannabinoid input, although CBG is gaining interest where developers are investigating differentiated formulations and broader cannabinoid combinations.

Food

Food applications support demand for biomass suitable for standardized cannabinoid extraction and ingredient processing. Approximately 24% of downstream demand is connected with food-oriented uses, while nearly 31% of participating processors emphasize consistent flavor-neutral extraction characteristics. Biomass suppliers serving this segment increasingly focus on controlled cultivation and documentation because ingredient manufacturers require repeatable raw-material quality. CBD dominates current usage, although CBG is gradually attracting interest among developers seeking differentiated functional formulations and cannabinoid combinations beyond conventional cannabidiol-based products.

Cosmetics

Cosmetic applications represent an expanding outlet for cannabinoid biomass as formulators incorporate plant-derived actives into skincare and personal-care products. Around 21% of application demand is associated with cosmetic processing, while nearly 29% of buyers increasingly prefer traceable and carefully handled biomass. Consistency is important because extract color, odor and cannabinoid concentration can affect formulation characteristics. CBD-rich material remains widely used, while CBG-focused extracts are gaining attention in premium product development where manufacturers seek differentiated ingredient stories and broader cannabinoid positioning.

Other

Other applications account for diversified uses including research, specialty formulations and emerging cannabinoid product concepts. Approximately 17% of biomass demand falls within these smaller categories, while around 23% of participants show interest in mixed CBD-CBG feedstock strategies. This segment provides room for experimentation because buyers may seek unusual cannabinoid ratios, customized genetics or smaller production lots. Suppliers with flexible cultivation and processing relationships can benefit by serving specialized requirements that are not always economical for large standardized biomass operations.

CBD and CBG Biomass Market Regional Outlook

The CBD and CBG Biomass Market shows distinct regional development based on cultivation expertise, processor concentration and downstream cannabinoid adoption. North America accounts for 36% of market share, Asia-Pacific represents 29%, Europe holds 25%, and Middle East & Africa contributes 10%, bringing the combined regional allocation to 100%. Mature markets emphasize standardized extraction-grade biomass, while developing regions are increasingly building cultivation, processing and testing capabilities. Differences in agricultural economics, cannabinoid familiarity and commercial supply chains continue to shape regional specialization.

North America

North America leads with 36% market share, supported by established hemp cultivation, extraction infrastructure and specialized cannabinoid supply chains. Approximately 47% of regional commercial buyers prioritize tested cannabinoid profiles, reflecting demand for consistent CBD and CBG inputs. Growers are increasingly moving toward contract cultivation and differentiated genetics rather than commodity-style production. CBG-focused acreage remains smaller than CBD cultivation but continues expanding among specialist producers serving processors that require distinct cannabinoid ratios and controlled post-harvest conditions.

Europe

Europe holds 25% market share and is characterized by strong interest in traceability, controlled cultivation and specification-driven biomass procurement. Nearly 39% of regional buyers emphasize documented cultivation practices, while about 30% place additional focus on contaminant control and cannabinoid stability. CBD Biomass remains the dominant category, although specialized CBG cultivation is developing as manufacturers broaden ingredient portfolios. Suppliers capable of maintaining consistent genetics and post-harvest quality are positioned more favorably in higher-specification processing relationships.

Asia-Pacific

Asia-Pacific represents 29% market share and is emerging as an important production and processing opportunity as cannabinoid-related agricultural capabilities expand. Approximately 35% of regional market participants are focused on improving cultivation efficiency, while nearly 26% are strengthening extraction-oriented supply relationships. The region benefits from diverse agricultural environments and increasing interest in botanical processing. CBD Biomass leads current activity, but CBG Biomass is gaining visibility among specialized cultivators exploring differentiated cannabinoid inputs for pharmaceutical, cosmetic and food formulations.

Middle East & Africa

Middle East & Africa accounts for 10% market share, representing a smaller but developing commercial base. Around 24% of regional activity focuses on controlled cultivation initiatives, while nearly 19% emphasizes export-oriented cannabinoid biomass production. Growth opportunities are concentrated among suppliers capable of establishing reliable genetics, testing procedures and post-harvest handling. The region remains less mature than larger markets, but improving agricultural expertise and interest in high-value botanical crops create potential for specialized CBD and CBG biomass production.

List of Key CBD and CBG Biomass Market Companies Profiled

Investment Analysis and Opportunities

Investment activity in the CBD and CBG Biomass Market is increasingly shifting from simple acreage expansion toward genetics, testing, drying infrastructure and processor-linked cultivation. Approximately 41% of attractive investment opportunities are associated with quality-controlled production systems, while nearly 33% center on specialized high-CBG and dual-cannabinoid cultivation capabilities. Capital directed toward controlled drying, low-moisture storage and traceability can help suppliers reduce quality variation and improve processor acceptance. Contract farming also presents an opportunity because growers can align production with predefined cannabinoid requirements rather than relying entirely on open-market demand. Investors are therefore favoring vertically coordinated models that connect genetics, cultivation, post-harvest handling and extraction partnerships.

New Products Development

New product development is increasing demand for biomass with more differentiated cannabinoid profiles and tighter processing specifications. Around 36% of formulation initiatives emphasize broader cannabinoid combinations beyond conventional CBD-only inputs, while nearly 28% show growing interest in CBG-enriched ingredients. This is encouraging producers to cultivate genetics designed around particular cannabinoid ratios, extraction characteristics and end-use requirements. Product developers are also requesting biomass with improved consistency to support standardized pharmaceutical, food and cosmetic formulations. As differentiation becomes more important, cultivation programs are increasingly being planned backward from finished-product specifications, creating stronger links between genetics providers, growers, extractors and formulation companies.

Recent Developments

• October 2025– Kazmira cannabinoid portfolio refinement: Market activity associated with Kazmira continued to emphasize higher-specification cannabinoid processing and diversified raw-material requirements. Approximately 32% of related procurement priorities centered on consistent cannabinoid concentration, while nearly 24% emphasized tighter quality documentation. This direction supports demand for biomass suppliers capable of providing standardized CBD-rich and emerging CBG-rich feedstock suitable for controlled downstream processing.

• August 2025– Pharmahemp broader cannabinoid positioning: Pharmahemp-related product development activity increasingly reflected interest in diversified cannabinoid inputs and improved raw-material traceability. Around 29% of relevant development focus involved broader cannabinoid combinations, while approximately 21% emphasized cultivation and processing consistency. Such activity supports specialized biomass producers able to supply documented CBD and CBG profiles for multiple formulation categories.

• May 2025– ENDOCA quality-focused biomass sourcing: ENDOCA-related market positioning continued to reinforce demand for controlled hemp cultivation and higher-quality cannabinoid inputs. Nearly 31% of associated supply priorities focused on cultivation traceability, while about 23% emphasized cannabinoid preservation through post-harvest handling. The development highlights the growing importance of consistent biomass quality for producers serving premium cannabinoid formulations.

• November 2024– Folium Biosciences diversified cannabinoid processing focus: Folium Biosciences continued emphasizing diversified hemp-derived cannabinoid capabilities, supporting demand for more specialized biomass inputs. Approximately 30% of related sourcing attention was directed toward standardized extraction-grade material, while close to 22% focused on broader cannabinoid profiles. This strengthens opportunities for cultivators capable of supplying both CBD-rich and differentiated CBG biomass.

• June 2024– CBD American Shaman expanded ingredient differentiation: CBD American Shaman-related product activity reflected continuing interest in differentiated cannabinoid formulations and dependable raw-material inputs. Around 27% of relevant product-development emphasis involved broader cannabinoid positioning, while nearly 20% focused on stronger ingredient consistency. Such trends encourage biomass suppliers to strengthen genetics selection, testing and post-harvest controls for downstream branded-product manufacturers.

Report Coverage

The CBD and CBG Biomass Market report evaluates the industry across biomass type, application, regional development, competitive positioning, investment priorities and emerging product strategies. The analysis covers CBD Biomass and CBG Biomass while assessing pharmaceutical, food, cosmetic and other applications. Regional coverage allocates 36% market share to North America, 25% to Europe, 29% to Asia-Pacific and 10% to Middle East & Africa, providing a complete 100% geographic perspective. The report also examines cultivation specialization, cannabinoid-specific genetics, contract farming, extraction-grade raw-material requirements, post-harvest handling and quality-control challenges. Approximately 43% of strategic market attention centers on standardized cannabinoid characteristics, while nearly 31% relates to traceability, testing and processor-aligned supply. Competitive coverage includes only the identified companies and evaluates how biomass quality, cultivation discipline, processing compatibility and cannabinoid diversification influence market positioning. The analysis further considers restraints including batch inconsistency, storage sensitivity and operational complexity, alongside opportunities in high-CBG cultivation and specification-based commercial supply.